136 related articles for article (PubMed ID: 1431220)
1. Fibronectin gene transcription is enhanced in abnormal wound healing.
Oliver N; Babu M; Diegelmann R
J Invest Dermatol; 1992 Nov; 99(5):579-86. PubMed ID: 1431220
[TBL] [Abstract][Full Text] [Related]
2. Fibronectin is overproduced by keloid fibroblasts during abnormal wound healing.
Babu M; Diegelmann R; Oliver N
Mol Cell Biol; 1989 Apr; 9(4):1642-50. PubMed ID: 2524650
[TBL] [Abstract][Full Text] [Related]
3. Fibronectin gene expression differs in normal and abnormal human wound healing.
Sible JC; Eriksson E; Smith SP; Smith N
Wound Repair Regen; 1994 Jan; 2(1):3-19. PubMed ID: 17168907
[TBL] [Abstract][Full Text] [Related]
4. DNA binding proteins from keloid fibroblasts form unique complexes with the human fibronectin promoter.
Sible JC; Eriksson E; Oliver N
Gene Expr; 1996; 5(6):269-83. PubMed ID: 8836736
[TBL] [Abstract][Full Text] [Related]
5. Studies of transforming growth factors beta 1-3 and their receptors I and II in fibroblast of keloids and hypertrophic scars.
Bock O; Yu H; Zitron S; Bayat A; Ferguson MW; Mrowietz U
Acta Derm Venereol; 2005; 85(3):216-20. PubMed ID: 16040405
[TBL] [Abstract][Full Text] [Related]
6. Gene expression patterns in isolated keloid fibroblasts.
Satish L; Lyons-Weiler J; Hebda PA; Wells A
Wound Repair Regen; 2006; 14(4):463-70. PubMed ID: 16939575
[TBL] [Abstract][Full Text] [Related]
7. Reduced hyaluronan in keloid tissue and cultured keloid fibroblasts.
Meyer LJ; Russell SB; Russell JD; Trupin JS; Egbert BM; Shuster S; Stern R
J Invest Dermatol; 2000 May; 114(5):953-9. PubMed ID: 10771477
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of transforming growth factor-beta1 and vascular endothelial growth factor in cultured keloid fibroblasts: relevance to angiogenic activity.
Fujiwara M; Muragaki Y; Ooshima A
Arch Dermatol Res; 2005 Oct; 297(4):161-9. PubMed ID: 16184401
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of fibroblast activation protein-alpha in keloid fibroblasts: implications for development of a novel treatment option.
Dienus K; Bayat A; Gilmore BF; Seifert O
Arch Dermatol Res; 2010 Dec; 302(10):725-31. PubMed ID: 20872224
[TBL] [Abstract][Full Text] [Related]
10. Bone marrow derived mesenchymal stem cells inhibit the proliferative and profibrotic phenotype of hypertrophic scar fibroblasts and keloid fibroblasts through paracrine signaling.
Fang F; Huang RL; Zheng Y; Liu M; Huo R
J Dermatol Sci; 2016 Aug; 83(2):95-105. PubMed ID: 27211019
[TBL] [Abstract][Full Text] [Related]
11. [The distrubution of cell cycle on fibrolasts derived from the pathlogical scars and analysis of Fas gene mutations in keloids using polymerse chain Reaction-based single-strand conformation polymorphism].
Lu F; Gao j ; Li X
Zhonghua Yi Xue Za Zhi; 2000 Sep; 80(9):709-12. PubMed ID: 11798842
[TBL] [Abstract][Full Text] [Related]
12. Thalidomide inhibits fibronectin production in TGF-β1-treated normal and keloid fibroblasts via inhibition of the p38/Smad3 pathway.
Liang CJ; Yen YH; Hung LY; Wang SH; Pu CM; Chien HF; Tsai JS; Lee CW; Yen FL; Chen YL
Biochem Pharmacol; 2013 Jun; 85(11):1594-602. PubMed ID: 23500539
[TBL] [Abstract][Full Text] [Related]
13. Differential glucocorticoid regulation of collagen mRNAs in human dermal fibroblasts. Keloid-derived and fetal fibroblasts are refractory to down-regulation.
Russell SB; Trupin JS; Myers JC; Broquist AH; Smith JC; Myles ME; Russell JD
J Biol Chem; 1989 Aug; 264(23):13730-5. PubMed ID: 2760040
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor-I enhances transforming growth factor-beta-induced extracellular matrix protein production through the P38/activating transcription factor-2 signaling pathway in keloid fibroblasts.
Daian T; Ohtsuru A; Rogounovitch T; Ishihara H; Hirano A; Akiyama-Uchida Y; Saenko V; Fujii T; Yamashita S
J Invest Dermatol; 2003 Jun; 120(6):956-62. PubMed ID: 12787120
[TBL] [Abstract][Full Text] [Related]
15. Gene profiling of keloid fibroblasts shows altered expression in multiple fibrosis-associated pathways.
Smith JC; Boone BE; Opalenik SR; Williams SM; Russell SB
J Invest Dermatol; 2008 May; 128(5):1298-310. PubMed ID: 17989729
[TBL] [Abstract][Full Text] [Related]
16. Epigenetically altered wound healing in keloid fibroblasts.
Russell SB; Russell JD; Trupin KM; Gayden AE; Opalenik SR; Nanney LB; Broquist AH; Raju L; Williams SM
J Invest Dermatol; 2010 Oct; 130(10):2489-96. PubMed ID: 20555348
[TBL] [Abstract][Full Text] [Related]
17. Regulation of collagen gene expression in keloids and hypertrophic scars.
Friedman DW; Boyd CD; Mackenzie JW; Norton P; Olson RM; Deak SB
J Surg Res; 1993 Aug; 55(2):214-22. PubMed ID: 8412102
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic differences between dermal fibroblasts from different body sites determine their responses to tension and TGFbeta1.
Chipev CC; Simon M
BMC Dermatol; 2002 Nov; 2():13. PubMed ID: 12445328
[TBL] [Abstract][Full Text] [Related]
19. Increased periostin expression affects the proliferation, collagen synthesis, migration and invasion of keloid fibroblasts under hypoxic conditions.
Zhang Z; Nie F; Kang C; Chen B; Qin Z; Ma J; Ma Y; Zhao X
Int J Mol Med; 2014 Jul; 34(1):253-61. PubMed ID: 24788198
[TBL] [Abstract][Full Text] [Related]
20. EDA Fibronectin in Keloids Create a Vicious Cycle of Fibrotic Tumor Formation.
Kelsh RM; McKeown-Longo PJ; Clark RAF
J Invest Dermatol; 2015 Jul; 135(7):1714-1718. PubMed ID: 26066891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
